Sec filing immatics
Web25 Mar 2024 · Immatics (NASDAQ:IMTX – Get Rating) – Equities researchers at SVB Leerink issued their Q1 2024 EPS estimates for Immatics in a report issued on Tuesday, March 21st.SVB Leerink analyst J. Chang anticipates that the company will post earnings per share of ($0.42) for the quarter. The consensus estimate for Immatics’ current full-year earnings … Web12 Apr 2024 · On Tuesday, XRP bucked the broader crypto market trend, falling by 0.08% to end the day at $0.51756. Updates from the SEC v Ripple case weighed on XRP. However, …
Sec filing immatics
Did you know?
WebSEC Filings All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. WebImmatics Announces Third Quarter 2024 Financial Results and Business Update Immatics Announces $110 Million Underwritten Offering of Ordinary Shares Immatics Announces Full Year 2024 Financial Results and Corporate Update Our PIPELINE INVESTORS Our Mission
WebOn June 1, 2024, Immatics US, Inc. entered into a License, Development and Commercialization agreement (the “Allogeneic ACT agreement”) with Bristol-Myer … Web9 Nov 2024 · SITC 2024 – Immatics’ T-cell receptor success was no fluke. After a long gestation T-cell receptor-based cell therapies were shown, courtesy of Adaptimmune and Immatics, to have a future after all. Today the latter company followed up an arguable early success with the project IMA203 by revealing improved signs of efficacy in more patients.
Web4 rows · Immatics’ international team, located in Munich and Tuebingen, Germany, as well as in Houston, ... WebUNITED STATES . SECURITIES AND EXCHANGE COMMISSION . Washington, D.C. 20549 . FORM 6-K. REPORT OF FOREIGN PRIVATE ISSUER . Pursuant to Rule 13a-16 or 15d-16. of the Securities Exc
Web22 Mar 2024 · Immatics N.V. (IMTX) SEC Filing 20-F Annual Report for the fiscal year ending Saturday, December 31, 2024. Home. SEC Filings. Immatics B.V. (IMTX) 20-F Annual Report Wed Mar 22 2024; SEC Filings. IMTX Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. Manager Portfolios. Notifications. IMTX Annual Reports. 20-F ...
Web14 Feb 2024 · Immatics N.V. (b) Address of Issuer's Principal Executive Offices Paul-Ehrlich-Strasse 15, Tubingen 72076 Item 2. (a) Name of Person Filing Wellington Management … thai lan travelWebBased on 76,227,038 Ordinary Shares (“Ordinary Shares”) of Immatics N.V. (the “Issuer”) outstanding as of October 12, 2024, as reported in the Issuer’s Prospectus filed with the … thai lao and phoWeb23 Mar 2024 · Immatics entered a global licensing agreement with Bristol Myers Squibb to collaborate on clinical development of TCR Bispecific (TCER ®) IMA401 targeting … thã¡i lan vã indonesiaWeb14 Dec 2024 · In November 2024, Immatics filed a Clinical Trial Application with Paul-Ehrlich-Institute (PEI), the German federal regulatory authority, for the development of IMA401. The clinical trial, which is planned to commence in the first half of 2024, is expected to enroll patients across various solid tumor types. syncler streamingWebImmatics Biotechnologies GmbH is located at Paul-Ehrlich Str. 15 in 72076 Tübingen, Germany. Immatics Biotechnologies GmbH was founded in September 2000 as a German … syncler setup troypointWebIMMATICS N.V. (Name of Issuer) Ordinary shares, nominal value €0.01 per share (Title of Class of Securities) N44445109 (CUSIP Number) December 31, 2024 (Date of Event … thai lan vs indonesia seagame 31http://investors.immatics.com/node/7756/html thailan us alliance how old